AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe

Core Insights - AVITA Medical has received the CE Mark for its RECELL GO device, allowing commercialization in Europe and other CE Mark-recognizing markets [1][2] - The RECELL GO device enables healthcare professionals to prepare a suspension of a patient's own skin cells to promote healing in burns and traumatic or surgical wounds [2] - Clinical data presented at the 2025 European Burns Association Congress showed a 36% reduction in hospital stays for adults with deep partial-thickness burns treated with RECELL compared to traditional grafting [3] Company Overview - AVITA Medical is a leading therapeutic acute wound care company focused on optimizing wound healing and accelerating patient recovery [5] - The RECELL System, which includes RECELL GO, is approved by the U.S. FDA for treating thermal burn and trauma wounds, utilizing a patient's own skin to create Spray-On Skin™ Cells [5][6] - In addition to RECELL, AVITA Medical holds exclusive rights to manufacture and distribute PermeaDerm and Cohealyx™, enhancing its product portfolio in wound care [5]